No. of patients | low survivin* | high survivin** | p-value | |
---|---|---|---|---|
n (%) | n (%) | |||
Age | ||||
≤ 56 years | 31 | 19 (53) | 12 (46) | 0.79 |
> 56 years | 31 | 17 (47) | 14 (54) | |
Sex | ||||
Male | 26 | 15 (42) | 11 (42) | 1.0 |
Female | 36 | 21 (58) | 15 (58) | |
HIV-status | ||||
Positive | 15 | 7 (19) | 8 (31) | 0.37 |
Negative | 47 | 29 (81) | 18 (69) | |
T-stage | ||||
T1/2 | 44 | 26 (72) | 18 (62) | 0.78 |
T3/4 | 17 | 9 (25) | 8 (31) | |
Tx | 1 | 1 (3) | 0 (0) | |
N-stage | ||||
N0 | 37 | 18 (50) | 19 (73) | 0.18 |
N+ | 23 | 16 (44) | 7 (27) | |
Nx | 2 | 2 (6) | 0 (0) | |
Grading | ||||
G1/2 | 47 | 27 (75) | 20 (77) | 0.75 |
G3 | 12 | 6 (17) | 6 (23) | |
Gx | 3 | 3 (8) | (0) |